• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[丁咯地尔与尼麦角林在急性脑缺血靶向治疗中的应用。随机对照双盲研究]

[Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].

作者信息

Bossi L

出版信息

Minerva Med. 1985 May 19;76(21):1005-18.

PMID:3889723
Abstract

Acute cerebral ischaemia may take considerable advantages of an adequate intensive therapy associated with a specific treatment of cerebral oedemas, especially in terms of mortality-rate reduction. Moreover, target treatment of acute cerebral ischaemia may produce excellent results in severe cases selected by means of EEG-chronospectrography. Double-blind, randomized comparison between nicergolin and buflomedil especialls showed that the latter reduces mortality three times as much as nicergolin, and leads to a 200% increment in the complete recovery of the "functio laesa", limited to those cases, which showed an appreciable improvement following EEG-chronospectrographical survey.

摘要

急性脑缺血若能结合针对脑水肿的特效治疗进行充分的强化治疗,可能会带来诸多益处,尤其是在降低死亡率方面。此外,通过脑电图时间频谱图选择的重症急性脑缺血病例,进行靶向治疗可能会产生极佳的效果。尼麦角林和丁咯地尔的双盲随机对照比较特别显示,后者降低死亡率的效果是尼麦角林的三倍,并且在脑电图时间频谱图检查后显示有明显改善的病例中,能使“功能受损”完全恢复的比例提高200%。

相似文献

1
[Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].[丁咯地尔与尼麦角林在急性脑缺血靶向治疗中的应用。随机对照双盲研究]
Minerva Med. 1985 May 19;76(21):1005-18.
2
[Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
Arzneimittelforschung. 1985;35(12):1865-70.
3
[Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].尼麦角林治疗慢性脑供血不足的疗效(作者译)
Nervenarzt. 1980 Jun;51(6):368-72.
4
Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
Eur Neurol. 1978;17 Suppl 1:159-66. doi: 10.1159/000115020.
5
[Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].尼麦角林治疗多发梗死性痴呆:两种给药方案的双盲、临床、心理测量及脑电图成像研究
Wien Med Wochenschr. 1987 Nov 30;137(22):513-24.
6
[Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].[尼麦角林在缺血后脑复苏中的价值:犬的实验研究]
Agressologie. 1987 Mar;28(3):341-6.
7
[Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
Minerva Cardioangiol. 1978 Jan-Feb;26(1-2):95-100.
8
[Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].用尼麦角林(喜得镇)治疗已证实的脑缺血
Ther Ggw. 1980 Dec;119(12):1478-85.
9
[Effect of nicergoline on the intellectual performance (author's transl)].
Rev Med Chil. 1979 Sep;107(9):817-9.
10
[Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].尼麦角林治疗36例脑血管疾病患者的神经生理学研究(作者译)
Arzneimittelforschung. 1979;29(8a):1301-7.

引用本文的文献

1
Buflomedil for acute ischaemic stroke.丁咯地尔治疗急性缺血性脑卒中
Cochrane Database Syst Rev. 2015 Jul 20;2015(7):CD009570. doi: 10.1002/14651858.CD009570.pub2.
2
A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline.一项评估尼麦角林不良事件概况和耐受性的系统评价与荟萃分析。
BMJ Open. 2014 Jul 30;4(7):e005090. doi: 10.1136/bmjopen-2014-005090.